keyword
https://read.qxmd.com/read/38391974/signaling-pathways-of-axl-receptor-tyrosine-kinase-contribute-to-the-pathogenetic-mechanisms-of-glioblastoma
#21
REVIEW
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, Lorenzo Colarossi, Angela Prestifilippo, Gabriele Pizzino, Irene Paterniti, Emanuela Esposito, Anna Paola Capra
Brain tumors are a diverse collection of neoplasms affecting the brain with a high prevalence rate in people of all ages around the globe. In this pathological context, glioblastoma, a form of glioma that belongs to the IV-grade astrocytoma group, is the most common and most aggressive form of the primary brain tumors. Indeed, despite the best treatments available including surgery, radiotherapy or a pharmacological approach with Temozolomide, glioblastoma patients' mortality is still high, within a few months of diagnosis...
February 19, 2024: Cells
https://read.qxmd.com/read/38388383/clinicopathological-analysis-of-rosette-forming-glioneuronal-tumors
#22
REVIEW
Jing Liu, Fan Lin, Yanhua Sun, Xia Liu
BACKGROUND: This study aimed to investigate the clinicopathological characteristics, diagnostic indicators, and critical factors for the differential diagnosis of rosette-forming glioneuronal tumor (RGNT). PATIENTS AND METHODS: This retrospective study included six surgically treated RGNT cases. We analyzed and summarized their clinical manifestations, radiological features, histological morphology, immunophenotype, and molecular genetic changes, supplemented with a literature review...
February 22, 2024: Diagnostic Pathology
https://read.qxmd.com/read/38385109/pilocytic-astrocytoma-the-paradigmatic-entity-in-low%C3%A2-grade-gliomas-review
#23
REVIEW
Cristina Pizzimenti, Vincenzo Fiorentino, Antonino Germanò, Maurizio Martini, Antonio Ieni, Giovanni Tuccari
Among low-grade gliomas, representing 10-20% of all primary brain tumours, the paradigmatic entity is constituted by pilocytic astrocytoma (PA), considered a grade 1 tumour by the World Health Organization. Generally, this tumour requires surgical treatment with an infrequent progression towards malignant gliomas. The present review focuses on clinicopathological characteristics, and reports imaging, neurosurgical and molecular features using a multidisciplinary approach. Macroscopically, PA is a slow-growing soft grey tissue, characteristically presenting in association with a cyst and forming a small mural nodule, typically located in the cerebellum, but sometimes occurring in the spinal cord, basal ganglia or cerebral hemisphere...
April 2024: Oncology Letters
https://read.qxmd.com/read/38380221/the-endonasal-endoscopic-transsphenoidal-approach-to-paediatric-optic-chiasma-glioma-a-case-report-and-literature-review
#24
Norah S Al Shareef, Ali Almomen, Retaj Alawadhi, Abdulrhman Alkhatib, Sultan Alsaiari
Optic pathway gliomas (OPGs) are rare pediatric tumors that pose significant challenges in management due to their location and clinical manifestations. Traditional transcranial approaches have been the mainstay for surgical intervention, but recent advancements in endoscopic endonasal transsphenoidal surgery offer a less invasive alternative. Here, we present a case of a 10-year-old female child with neurofibromatosis type-1 and an aggressive OPG who underwent endoscopic endonasal transsphenoidal debulking surgery...
January 2024: Curēus
https://read.qxmd.com/read/38376530/brain-stem-tumors-in-children-less-than-3%C3%A2-months-clinical-and-radiologic-findings-of-a-rare-disease
#25
JOURNAL ARTICLE
Danai Papangelopoulou, Brigitte Bison, Lars Behrens, Simon Bailey, Marc Ansari, Karoline Ehlert, Ofelia Cruz Martinez, Christof M Kramm, Andres Morales La Madrid, Andre O von Bueren
PURPOSE: Brain stem tumors in children < 3 months at diagnosis are extremely rare. Our aim is to study a retrospective cohort to improve the understanding of the disease course and guide patient management. METHODS: This is a multicenter retrospective analysis across the European Society for Pediatric Oncology SIOP-E HGG/DIPG Working Group linked centers, including patients with a brainstem tumor diagnosed between 2009 and 2020 and aged < 3 months at diagnosis...
February 20, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38353806/distant-recurrence-in-the-cerebellar-dentate-nucleus-through-the-dentato-rubro-thalamo-cortical-pathway-in-supratentorial-glioma-cases
#26
JOURNAL ARTICLE
Masayuki Kanamori, Yohei Morishita, Yoshiteru Shimoda, Eiko Yamamori, Shiho Sato, Yoshinari Osada, Shin-Ichiro Osawa, Ichiyo Shibahara, Ryuta Saito, Yukihiko Sonoda, Toshihiro Kumabe, Hidenori Endo
BACKGROUND: Distant recurrence can occur by infiltration along white matter tracts or dissemination through the cerebrospinal fluid (CSF). This study aimed to clarify the clinical features and mechanisms of recurrence in the dentate nucleus (DN) in patients with supratentorial gliomas. Based on the review of our patients, we verified the hypothesis that distant DN recurrence from a supratentorial lesion occurs through the dentato-rubro-thalamo-cortical (DRTC) pathway. METHODS: A total of 380 patients with supratentorial astrocytoma, isocitrate dehydrogenase (IDH)-mutant (astrocytoma), oligodendroglioma, IDH mutant and 1p/19q-codeleted (oligodendroglioma), glioblastoma, IDH-wild type (GB), and thalamic diffuse midline glioma, H3 K27-altered (DMG), who underwent tumor resection at our department from 2009 to 2022 were included in this study...
February 14, 2024: Acta Neurochirurgica
https://read.qxmd.com/read/38347794/naringenin-nanoformulations-for-neurodegenerative-diseases
#27
JOURNAL ARTICLE
Liza Sahoo, Nigam Sekhar Tripathy, Fahima Dilnawaz
Glioblastoma (GBM) is a grade-IV astrocytoma, which is the most common and aggressive type of brain tumor, spreads rapidly and has a life-threatening catastrophic effect. GBM mostly occurs in adults with an average survival time of 15 to 18 months, and the overall mortality rate is 5%. Significant invasion and drug resistance activity cause the poor diagnosis of GBM. Naringenin (NRG) is a plant secondary metabolite byproduct of the flavanone subgroup. NRG can cross the blood-brain barrier and deliver drugs into the central nervous system when conjugated with appropriate nanocarriers and can overcome the challenges associated with gliomas through naringenin-loaded nanoformulations...
February 12, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38347151/patterns-of-t2-flair-discordance-across-a-cohort-of-adult-type-diffuse-gliomas-and-deviations-from-the-classic-t2-flair-mismatch-sign
#28
JOURNAL ARTICLE
Prateek Malik, Radwa Soliman, Yingming Amy Chen, David G Munoz, Sunit Das, Aditya Bharatha, Shobhit Mathur
PURPOSE: T2-FLAIR mismatch serves as a highly specific but insensitive marker for IDH-mutant (IDHm) astrocytoma with potential limitations in real-world application. We aimed to assess the utility of a broader definition of T2-FLAIR discordance across a cohort of adult-type diffuse lower-grade gliomas (LrGG) to see if specific patterns emerge and additionally examine factors determining deviation from the classic T2-FLAIR mismatch sign. METHODS: Preoperative MRIs of non-enhancing adult-type diffuse LrGGs were reviewed...
February 13, 2024: Neuroradiology
https://read.qxmd.com/read/38339779/idh-mutation-glioma-immunogenicity-and-therapeutic-challenge-of-primary-mismatch-repair-deficient-idh-mutant-astrocytoma-pmmrdia-a-systematic-review
#29
REVIEW
Olfat Ahmad, Tahani Ahmad, Stefan M Pfister
In 2021, Suwala et al. described Primary Mismatch Repair Deficient IDH-mutant Astrocytoma (PMMRDIA) as a distinct group of gliomas. In unsupervised clustering, PMMRDIA forms distinct cluster, separate from other IDH-mutant gliomas, including IDH-mutant gliomas with secondary mismatch repair (MMR) deficiency. In the published cohort, three patients received treatment with an immune checkpoint blocker (ICB), yet none exhibited a response, which aligns with existing knowledge about the decreased immunogenicity of IDH-mutant gliomas in comparison to IDH-wildtype...
February 9, 2024: Molecular Oncology
https://read.qxmd.com/read/38334738/-laser-fluorescence-spectroscopy-and-navigation-in-surgical-treatment-of-spinal-tumors-a-systematic-review
#30
JOURNAL ARTICLE
N A Konovalov, S V Kaprovoy, Yu M Poluektov, R A Onoprienko, A A Aristov
UNLABELLED: The main problem in microsurgical resection of spinal cord tumors is excessive surgical aggression. The last one often leads to unsatisfactory clinical and neurological outcomes. Laser fluorescence spectroscopy is a modern neurosurgical approach to distinguish tumor boundaries even if standard visible fluorescence techniques are ineffective. OBJECTIVE: To evaluate the effectiveness of laser fluorescence spectroscopy alone or in combination with visual 5-ALA fluorescence for improvement of safety and quality of resection, as well as intraoperative diagnosis...
2024: Zhurnal Voprosy Neĭrokhirurgii Imeni N. N. Burdenko
https://read.qxmd.com/read/38330474/spinal-cord-neoplasms
#31
JOURNAL ARTICLE
J Ricardo McFaline-Figueroa
OBJECTIVE: This article discusses the diagnostic approach to patients with suspected neoplasms of the spinal cord and reviews the most common primary and metastatic spinal neoplasms and their presentations. LATEST DEVELOPMENTS: Neoplasms of the spinal cord are rare entities that can involve the spinal cord parenchyma, the dura and leptomeninges, or the extradural space. The most common intramedullary spinal cord neoplasms are primary spinal cord tumors, including ependymomas, pilocytic astrocytomas, and diffuse midline gliomas...
February 1, 2024: Continuum: Lifelong Learning in Neurology
https://read.qxmd.com/read/38326661/treatment-outcome-of-idh1-2-wildtype-cns-who-grade-4-glioma-histologically-diagnosed-as-who-grade-ii-or-iii-astrocytomas
#32
JOURNAL ARTICLE
Naureen Keric, Harald Krenzlin, Darius Kalasauskas, Christian F Freyschlag, Oliver Schnell, Martin Misch, Christian von der Brelie, Jens Gempt, Aleksandrs Krigers, Arthur Wagner, Felipa Lange, Dorothee Mielke, Clemens Sommer, Marc A Brockmann, Bernhard Meyer, Veit Rohde, Peter Vajkoczy, Jürgen Beck, Claudius Thomé, Florian Ringel
BACKGROUND: Isocitrate dehydrogenase (IDH)1/2 wildtype (wt) astrocytomas formerly classified as WHO grade II or III have significantly shorter PFS and OS than IDH mutated WHO grade 2 and 3 gliomas leading to a classification as CNS WHO grade 4. It is the aim of this study to evaluate differences in the treatment-related clinical course of these tumors as they are largely unknown. METHODS: Patients undergoing surgery (between 2016-2019 in six neurosurgical departments) for a histologically diagnosed WHO grade 2-3 IDH1/2-wt astrocytoma were retrospectively reviewed to assess progression free survival (PFS), overall survival (OS), and prognostic factors...
February 7, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38322836/expression-of-lncrnas-in-glioma-a-lighthouse-for-patients-with-glioma
#33
REVIEW
Xiaolin Lu, Dongzhi Zhang
Glioma is the most common malignant tumour in the central nervous system, accounting for approximately 30 % of the primary tumours of this system. The World Health Organization grades for glioma include: Grade I (pilocytic astrocytoma), Grade II (astrocytoma, oligodastoma, etc.), Grade III (anaplastic astrocytoma, anaplastic oligodastoma, etc.) and Grade IV (glioblastoma). With grade increases, the proliferation, invasion and other malignant biological properties of the glioma are enhanced, and the treatment results are less satisfactory...
February 15, 2024: Heliyon
https://read.qxmd.com/read/38306557/bilateral-thalamic-and-brainstem-anaplastic-astrocytoma-a-case-report
#34
JOURNAL ARTICLE
Hong Zhang, Ping Zhang, Hongbing Nie, Ji Zhang, Jie Li, Xiaoqing Lu, Yaoyao Shen
RATIONALE: Bilateral thalamic glioma is extremely rare and characterized by strictly limited involvement of bilateral thalami. To investigate its clinical and neuroimaging features, we herein reported a rare case of anaplastic astrocytoma (AA) involving both thalami and the brainstem and reviewed the literature. PATIENT CONCERNS: A-33-year-old Chinese woman was referred to our department owing to persistent headache and nausea and vomiting. Neurological examination showed mild cognitive impairment and positive Kernig sign...
February 2, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38301236/radiographic-growth-rate-as-a-predictor-of-aggressiveness-of-diffuse-gliomas-without-1p19q-codeletion
#35
JOURNAL ARTICLE
Arthur Leclerc, Alexandre Roux, Angela Elia, Sophie Peeters, Oumaima Aboubakr, Aziz Bedioui, Martin Planet, Joseph Benzakoun, Giorgia Antonia Simboli, Arnault Tauziede-Espariat, Alessandro Moiraghi, Pascale Varlet, Fabrice Chrétien, Catherine Oppenheim, Marc Zanello, Johan Pallud
OBJECTIVE: The 2021 WHO classification of CNS tumors has refined the definition of adult-type diffuse gliomas without 1p19q codeletion. Nevertheless, the aggressiveness of gliomas is based exclusively on histomolecular criteria performed on a limited sample of the tumor. The authors aimed to assess whether the spontaneous radiographic tumor growth rate is associated with tumor aggressiveness and allows preoperative identification of malignancy grade of adult-type diffuse gliomas without 1p19q codeletion...
February 2024: Neurosurgical Focus
https://read.qxmd.com/read/38299304/novel-insights-on-genetics-and-epigenetics-as-clinical-targets-for-paediatric-astrocytoma
#36
REVIEW
Dona A Johns, Richard J Williams, Craig M Smith, Pavani P Nadaminti, Rasika M Samarasinghe
Paediatric and adult astrocytomas are notably different, where clinical treatments used for adults are not as effective on children with the same form of cancer and these treatments lead to adverse long-term health concerns. Integrative omics-based studies have shown the pathology and fundamental molecular characteristics differ significantly and cannot be extrapolated from the more widely studied adult disease. Recent clinical advances in our understanding of paediatric astrocytomas, with the aid of next-generation sequencing and epigenome-wide profiling, have led to the identification of key canonical mutations that vary based on the tumour location and age of onset...
February 2024: Clinical and Translational Medicine
https://read.qxmd.com/read/38281032/a-system-review-of-central-nervous-system-tumors-on-children-in-china-epidemiology-and-clinical-characteristics
#37
JOURNAL ARTICLE
Bing Yao, Hongying Wang, Xiaomei Wu, Chenyu Wang, Tao Tang, Wenxiu An, Bo Zhu
BACKGROUND: Central nervous system (CNS) tumors are the most common solid tumors in children and the leading cause of cancer-related death in the latter. Currently, the incidence rate exceeds that of leukemia and ranks first in the incidence of malignant tumors in children. METHODS: The epidemiological data on childhood CNS tumors were collected from the Chinese Cancer Registry Annual Report. The annual percent change (APC) of incidence and mortality-rate changes were estimated via Joinpoint regression...
January 27, 2024: BMC Cancer
https://read.qxmd.com/read/38279985/national-multicentered-retrospective-review-of-clinical-and-intraoperative-factors-associated-with-the-development-of-cerebellar-mutism-after-pediatric-posterior-fossa-tumor-resection
#38
JOURNAL ARTICLE
Michelle M Kameda-Smith, Malavan Ragulojan, Cameron Elliott, Lori Bliss, Hanna Moore, Nicholas Sader, Mosaab Alsuwaihel, Michael K Tso, Ayoub Dakson, Olufemi Ajani, Blake Yarascavitch, Adam Fleming, Vivek Mehta, Minoo Aminnejad, Forough Farrokhyar, Sheila K Singh
BACKGROUND: Cerebellar mutism (CM) is characterized by a significant loss of speech in children following posterior fossa (PF) surgery. The biological origin of CM remains unclear and is the subject of ongoing debate. Significant recovery from CM is less likely than previously described despite rigorous multidisciplinary neuro-rehabilitational efforts. METHODS: A national multi-centered retrospective review of all children undergoing PF resection in four midsized Canadian academic pediatric institutions was undertaken...
January 27, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38265392/application-of-quercetin-and-its-novel-formulations-in-the-treatment-of-malignancies-of-central-nervous-system-an-updated-review-of-current-evidence-based-on-molecular-mechanisms
#39
JOURNAL ARTICLE
Mohammad Saleh Jamshidi-Mouselou, Amirhossein Hashemi, Mohammad Sobhan Jamshidi-Mouselou, Tahereh Farkhondeh, Mohammad Hossein Pourhanifeh, Saeed Samarghandian
Quercetin, a naturally occurring polyphenolic compound found in abundance in vegetables and fruits, has emerged as a compelling subject of study in cancer treatment. This comprehensive review delves into the significance and originality of quercetin's multifaceted mechanisms of action, with a particular focus on its application in various brain tumors such as glioblastoma, glioma, neuroblastoma, astrocytoma, and medulloblastoma. This review scrutinizes the distinctive facets of quercetin's anti-cancer properties, highlighting its capacity to modulate intricate signaling pathways, trigger apoptosis, impede cell migration, and enhance radiosensitivity in brain tumor cells...
January 23, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38243818/prognostic-value-of-dna-methylation-subclassification-aneuploidy-and-cdkn2a-b-homozygous-deletion-in-predicting-clinical-outcome-of-idh-mutant-astrocytomas
#40
JOURNAL ARTICLE
Kristyn Galbraith, Mekka Garcia, Siyu Wei, Anna Chen, Chanel Schroff, Jonathan Serrano, Donato Pacione, Dimitris G Placantonakis, Christopher M William, Arline Faustin, David Zagzag, Marissa Barbaro, Maria Del Pilar Guillermo Prieto Eibl, Mitsuaki Shirahata, David Reuss, Quynh T Tran, Zahangir Alom, Andreas von Deimling, Brent A Orr, Erik P Sulman, John G Golfinos, Daniel A Orringer, Rajan Jain, Evan Lieberman, Yang Feng, Matija Snuderl
INTRODUCTION: IDH mutant astrocytoma grading, until recently, has been entirely based on morphology. The 5th edition of the Central Nervous System WHO introduces CDKN2A/B homozygous deletion as a biomarker of grade 4. We sought to investigate the prognostic impact of DNA methylation-derived molecular biomarkers for IDH mutant astrocytoma. METHODS: We analyzed 98 IDH mutant astrocytomas diagnosed at NYU Langone Health between 2014 and 2022. We reviewed DNA methylation subclass, CDKN2A/B homozygous deletion, and ploidy and correlated molecular biomarkers with histological grade, progression free (PFS), and overall (OS) survival...
January 19, 2024: Neuro-oncology
keyword
keyword
113782
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.